Mazda Motor Corp. will start launching new electrified vehicle models next year with a goal of offering 13 new variants globally by 2025, including three electric vehicles, five gas-electric hybrids, and five plug-in hybrids.
The plan is part of Mazda’s goal of making a quarter of its lineup of electric vehicles by 2030 and eventually electrifying all of its cars.
By 2025, Mazda focus on using a dedicated platform now under development developing electric vehicles.
Next year, the carmaker is set to release its first autonomous car, whch would be equipped with Level 2 self-driving technology that controls steering, braking, and acceleration.
However, its self-driving system is activated only when it detects emergencies affecting the drives, such as medical issues.
The vehicle is designed to pull over the roadside while verifying the safety of its environment.


Asian Stock Markets Trade Flat as Holiday Liquidity Thins and BOJ Minutes Watched
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Global Markets Rise as Tech Stocks Lead, Yen Strengthens, and Commodities Hit Record Highs
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Gold Prices Surge to Record Highs as Geopolitical Tensions Fuel Safe-Haven Demand
Asian Markets Rise as AI Rally Caps 2025, Gold and Silver Hit Record Highs
US and Japan Fast-Track $550 Billion Strategic Investment Initiative
German Exports to the U.S. Decline Sharply as Tariffs Reshape Trade in 2025
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
China Keeps Benchmark Lending Rates Steady as Economic Outlook Remains Cautious
Asian Stocks Rise as Wall Street Tech Rally Lifts Markets, Yen Slumps Despite BOJ Rate Hike
Japan Revises Economic Growth Forecast as Stimulus Fuels Consumption and Investment
Platinum Price Surges Past $2,000 as Demand and Supply Dynamics Tighten
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
FDA Approves Mitapivat for Anemia in Thalassemia Patients 



